Acasti Pharma (ACST) Stock Surges Following Major Clinical Trial Milestone
The shares of Acasti Pharma Inc. (NASDAQ: ACST) saw a sharp rise when the company reported that its clinical studies were making substantial progress. The
The shares of Acasti Pharma Inc. (NASDAQ: ACST) saw a sharp rise when the company reported that its clinical studies were making substantial progress. The
Acasti Pharma Inc. (ACST) shares were rising 22.04% to trade at $0.659 in after-hours at last check. As of the last check, shares of Ascasti
Lizhi Inc. (LIZI) stock plunged -8.14% to $4.4 in the pre-market trading after reporting that it entered in-car audio collaboration with Xpeng Motors. The most
BlackBerry Limited (BB) stock soared 21.29% to $8.49 in the pre-market trading following the announcement of its multi-year, global agreement with Amazon Web Services, Inc.
AnPac Bio-Medical Science Co. Ltd. (ANPC) stock plunged 0.0% to $7.14 in the pre-market trading after announcing that it experienced strong demand for its cancer
Oncternal Therapeutics Inc. (ONCT) stock soared 2.42% to $2.96 in the pre-market trading as the company raised the size of the formerly publicized offering and
Alterity Therapeutics Limited (ATHE) stock plunged -10.31% to $2.0 in the pre-market trading after the company announced the approval of a US patent for the
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.